{
  "actions": [
    {
      "acted_at": "2000-09-27", 
      "committee": "Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned", 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2000-09-27", 
      "committee": "House Commerce", 
      "references": [], 
      "text": "Referred to House Commerce", 
      "type": "referral"
    }, 
    {
      "acted_at": "2000-09-27", 
      "committee": "House Judiciary", 
      "references": [], 
      "text": "Referred to House Judiciary", 
      "type": "referral"
    }, 
    {
      "acted_at": "2000-10-20", 
      "in_committee": "House Commerce", 
      "references": [], 
      "subcommittee": "Health and Environment", 
      "text": "Referred to the Subcommittee on Health and Environment.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr5313-106", 
  "bill_type": "hr", 
  "committees": [
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health and Environment", 
      "subcommittee_id": "04"
    }, 
    {
      "activity": [
        "referral", 
        "in committee"
      ], 
      "committee": "House Judiciary", 
      "committee_id": "HSJU"
    }
  ], 
  "congress": "106", 
  "cosponsors": [], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2000-09-27", 
  "number": "5313", 
  "official_title": "To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.", 
  "popular_title": null, 
  "related_bills": [], 
  "short_title": "Drug Competition Act of 2000", 
  "sponsor": {
    "district": "1", 
    "name": "Andrews, Robert E.", 
    "state": "NJ", 
    "thomas_id": "00021", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2000-09-27", 
  "subjects": [
    "Actions and defenses", 
    "Administrative procedure", 
    "Antitrust law", 
    "Commerce", 
    "Drug approvals", 
    "Drug industry", 
    "Federal Trade Commission", 
    "Fines (Penalties)", 
    "Generic drugs", 
    "Government operations and politics", 
    "Government paperwork", 
    "Health", 
    "Independent regulatory commissions", 
    "Injunctions", 
    "Law", 
    "Marketing", 
    "Pharmaceutical research", 
    "Research and development", 
    "Restrictive trade practices", 
    "Science, technology, communications"
  ], 
  "subjects_top_term": "Commerce", 
  "summary": {
    "as": "Introduced", 
    "date": "2000-09-27", 
    "text": "Drug Competition Act of 2000 - Requires brand name drug manufacturers and generic drug manufacturers to notify the Federal Trade Commission and the Attorney General of agreements regarding the sale or manufacture of generic drugs which could have the effect of limiting the research, development, manufacture, marketing, or selling of a generic drug product."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Drug Competition Act of 2000", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To enhance competition for prescription drugs by increasing the ability of the Department of Justice and Federal Trade Commission to enforce existing antitrust laws regarding brand name drugs and generic drugs.", 
      "type": "official"
    }
  ], 
  "updated_at": "2013-07-14T18:55:10-04:00"
}